Two RSV Shots to Carry Neurological Risk Warning

Published on January 8, 2025

GSK and Pfizer’s respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing a rare neurological disorder, the U.S. Food Drug Administration said on Tuesday. The regulator conducted a postmarketing trial which suggested…

Read Full Article (External Site)